| [1] | World Health Organization (2009) Global Leprosy Situation 2009. Wkly Epidemiol Rec 33: 333–40.
|
| [2] | Ridley DS, Jopling WH (1966) Classification of leprosy according to immunity: a five-group system. Int J Lepr 34: 255–73.
|
| [3] | Congresso de Madrid (1953) Classifica？？o, Resolu？？o Técnica, VI Congresso Internacional de Leprologia. Int J Lepr 21: 504–16.
|
| [4] | Jopling WH (1978) Leprosy reactions (reactional states). Handbook of leprosy. 2.ed. London: Willian Heinemann Medical Books. pp. 66–74.
|
| [5] | Souza Lima, Souza Campos (1947) Leprides tuberculóides reacionais. In: Lepra tuberculóide: estudo clínico histopatológico. S？o Paulo: Renascen？a. pp. 173–215.
|
| [6] | Fujieda S, Sieling PA, Modlin RL, Saxon A (1998) CD1-restricted T-cells influence IgG subclass and IgE production. J Allergy Clin Immunol 101: 545–51. doi: 10.1016/S0091-6749(98)70362-8
|
| [7] | Silva CL, Faccioli LH, Foss NT (1993) Supression of human monocyte cytokine release by phenolic glycolipid-I of Mycobacterium leprae. Int J Lepr 61: 107–8.
|
| [8] | Ridley DS (1987) Reacciones. La biopsia de piel en la lepra. 2.ed. Basilea: Ciba-Geigy. pp. 53–8.
|
| [9] | Ridley DS, Radia KB (1981) The histological course of reactions in borderline leprosy and their outcome. Int J Lepr 49: 383–92.
|
| [10] | Lockwood DN, Lucas SB, Desikan KV, Ebenezer G, Suneetha S, et al. (2008) The diagnosis of leprosy type 1 reactions: identification of key variables and an analysis of the process of histological diagnosis. J Clin Pathol 61: 595–600. doi: 10.1136/jcp.2007.053389
|
| [11] | Trindade MAB (1996) Evolu？？o histológica de reativa？？es da hanseníase durante ou após o tratamento. 63 p. http://pesquisa.bvsalud.org/regional/res？ources/lil-204390 accessed on 27/03/2010.
|
| [12] | Ridley DS, Hilson GRF (1967) A logarithmic index of bacilli in biopsies. Int J Lep 35: 184–186.
|
| [13] | Katoch K, Ramanathan U, Natrajan M, Bagga AK, Bhatia AS, et al. (1989) Relapses in paucibacillary patients after treatment with three short-term regimens containing rifampin. Int J Lepr Other Mycobact Dis 57: 458–64.
|
| [14] | Naafs B, Wheate HW (1978) The time interval between the start of anti-leprosy treatment and the development of reactions in borderline patients. Lepr Rev 49: 153–7.
|
| [15] | Opromolla DVA (1994) Recidiva ou rea？？o reversa. Hansen Int 19: 10–6.
|
| [16] | Barreto JA, Belone AFF, Fleury RN, Soares CT, Lauris JRP (2005) Manifestations of reactional tuberculoid pattern in borderline leprosy: comparative, histochemical and immunohistochemical study, in skin biopsies, between type 1 reactions occurred before and during multidrugtherapy. An Bras Dermatol 80: S268–74.
|
| [17] | Opromolla DVA (1995) Alguns comentários acerca de um caso relatado por Wade e Rodriguez nos anos 30. Hansen Int 20: 29–37.
|
| [18] | Becx-Bleumink M, Berhe D (1992) Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the all Africa leprosy and rehabilitation training center (ALERT) in Etiopia. Int J Lepr 60: 173–84.
|
| [19] | Desikan KV (1995) Relapse, reactivation or reinfection? Indian J Lepr. 67. : 3–11. [Symposium paper].
|
| [20] | Jamet P, Baohong J, Marchoux Chemotherapy Study Group (1995) Relapse after long-term follow up of multibacillary patients treated by WHO multidrug regimen. Int J Lepr 63: 195–201.
|
| [21] | Khanolkar-Young S, Rayment N, Brickell PM, Katz DR, Vinayakumar S, et al. (1995) Tumour necrosis factor-alpha (TNF-alpha) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions. Clin Exp Immunol 99: 196–20. doi: 10.1111/j.1365-2249.1995.tb05532.x
|
| [22] | Little D, Khanolkar-Young S, Coulthart A, Suneetha S, Lockwood DN (2001) Immunohistochemical analysis of cellular infiltrate and gamma interferon, interleukin-12, and inducible nitric oxide synthase expression in leprosy type 1 (reversal) reactions before and during prednisolone treatment. Infect Immun 69: 3413–7. doi: 10.1128/IAI.69.5.3413-3417.2001
|
| [23] | Trindade MAB, Manini MIP, Masetti JH, Leite MA, Takahashi MD, et al. (2005) Leprosy and HIV co-infection in five patients. Lepr Rev 76: 162–6.
|
| [24] | Trindade MAB, Valente NYS, Manini MIP, Takahashi MDF, Anjos CFD, et al. (2006) Two patients coinfected with Mycobacterium Leprae and Human Immunodeficiency Virus Type 1 and naive for antiretroviral therapy who exhibited Type 1 Leprosy Reactions mimicking the Immune Reconstitution Inflammatory Syndrome. Journal of Clinical Microbiology 44: 4616–18. doi: 10.1128/JCM.01425-06
|
| [25] | Batista MD, Porro AM, Maeda SM, Gomes EE, Yoshioka MC, et al. (2008) Leprosy reversal reaction as immune reconstitution inflammatory syndrome in patients with AIDS. Clin Infect Dis 46: e56–60. doi: 10.1086/528864
|
| [26] | Deps PD, Lockwood DNJ (2008) Leprosy occurring as immune reconstitution syndrome. Trans R Soc Trop Med Hyg 30: 966–8. doi: 10.1016/j.trstmh.2008.06.003
|
| [27] | Sarno EN, Illarramendi X, Nery JA, Sales AM, Gutierrez-Galhardo MC, et al. (2008) HIV-M. leprae interaction: can HAART modify the course of leprosy? Public Health Rep 123: 206–12.
|
| [28] | Kar HK, Sharma P, Bhardwaj M (2009) Borderline tuberculoid leprosy with upgrading Type 1 reaction in a HIV seropositive patient, after antiretroviral therapy: an immune reconstitution inflammatory syndrome. Lepr Rev 80: 85–8.
|
| [29] | Couppié P, Abel S, Voinchet H, Roussel M, Hélénon R, et al. (2004) Immune reconstitution inflammatory syndrome associated with HIV and leprosy. Arch Dermatol 140: 997–1000. doi: 10.1001/archderm.140.8.997
|
| [30] | Job CK (1995) Histopathological features of relapsed leprosy. Indian J Lepr 67: 69–80. [Symposium paper].
|
| [31] | Opromolla DVA (2005) Some considerations on the origin of type 1 reactions in leprosy. Int J Lepr 73: 33–4. [Correspondence].
|
